Delivery Order SPE2DB24D2109-SPE2DB25FHXZF
Award Date 9/26/25
Potential Completion Date 9/29/25
Potential Value $3.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication commonly used to treat benign prostatic hyperplasia. The contract, awarded on August 18, 2025, carries a ceiling value of $2,029.15 with a firm fixed price structure and an ultimate completion date of August 19, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This was a competitively awarded...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication commonly used to treat urinary symptoms associated with benign prostatic hyperplasia. This non-set-aside, competitively awarded contract is structured as a firm fixed price delivery order with a ceiling value of $5,073.32 and an ultimate completion date of September 5, 2025. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication commonly used to treat benign prostatic hyperplasia. This competitive delivery order, valued at $2,750.29 with firm fixed pricing, was awarded on August 6, 2025, with an ultimate completion date of August 7, 2025. The contract includes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $3,379.76 to AmerisourceBergen Drug Corp for the supply of Tamsulosin HCL 0.4 mg capsules (1,000 units). This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of July 14, 2025. The award represents procurement of a generic medication commonly used to treat urinary symptoms associated with benign prostatic hyperplasia, supporting the federal government's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of 1,000 units of Tamsulosin HCL 0.4 mg capsules under a firm fixed price contract valued at $2,008.55. The delivery order was competitively awarded without a set-aside designation and is scheduled for completion by August 6, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 capsules of Tamsulosin HCL 0.4 mg, valued at $1,322.61 with firm fixed pricing. The order, issued on August 22, 2025, carries an ultimate completion date of August 25, 2025, and represents a non-set-aside competitive award. Performance will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,416.63 to AmerisourceBergen Drug Corp for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 7, 2025. Performance will be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication commonly prescribed for benign prostatic hyperplasia treatment, with a contract value of $1,279.81. The award, issued on July 28, 2025, carries a firm fixed price structure with an ultimate completion date of July 29, 2025. The contract represents a non-set-aside award issued through open competition, reflecting AmerisourceBergen's continued qualification...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,374.62 to AmerisourceBergen Drug Corp for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg. This non-competitive delivery order, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a firm fixed-price pharmaceutical procurement contract. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,738.42 on August 5, 2025, for the supply of Tamsulosin HCL 0.4 mg capsules (1,000 count). This award is non-competitive and carries a firm fixed price structure with completion targeted for August 6, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under a larger...